212 filings
Page 3 of 11
8-K
g55e 6u8nb8c
2 Nov 22
Seres Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
7:10am
8-K
6uiwgg2lldn 86h9
3 Aug 22
Seres Therapeutics Reports Second Quarter 2022 Financial Results and Provides
7:15am
8-K
20b2a5xunr6ndny
30 Jun 22
Entry into a Material Definitive Agreement
8:02am
424B5
9mi0rk6
30 Jun 22
Prospectus supplement for primary offering
7:59am
8-K
skapp7 4m3g9
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:04pm
8-K
o6rqpbh
7 Jun 22
Regulation FD Disclosure
7:36am
EFFECT
u5gpn
6 May 22
Notice of effectiveness
12:00am
POS AM
acckrj74ykuuw6uiq
4 May 22
Prospectus update (post-effective amendment)
4:03pm
8-K
3t5ersc7smn 8k0
4 May 22
Seres Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates
7:11am
DEFA14A
p00re
29 Apr 22
Additional proxy soliciting materials
12:00am
8-K
pcrxxm
6 Apr 22
Regulation FD Disclosure
7:00am
POS AM
10dancy 517y1
1 Mar 22
Prospectus update (post-effective amendment)
11:02am
S-8
kac nayjwzney
1 Mar 22
Registration of securities for employees
10:31am
POSASR
jvtkv2bp9z4hq7id847c
1 Mar 22
Automatic shelf registration (post-effective amendment)
9:40am
8-K
p49ox7svf94gxsbj3p
1 Mar 22
Seres Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
7:07am